U.S. Drug Companies Investigated for Price Collusion (Audio)

Jeffrey Jacobovitz, a partner at Arnall Golden Gregory and former vice-chair of the ABA’s Antitrust Criminal Antitrust Committee, and David McLaughlin, a reporter for Bloomberg news, discuss an investigation into whether or not drug companies are colluding to fix prices of generic drugs. They speak with Bloomberg’s Greg Stohr and Michael Best on Bloomberg Radio’s “Bloomberg Law.” For more information, please click here.

Related Services